ADVERTISEMENT
Videos
James N. Kochenderfer, MD, Discusses the KarMMa Clinical Trial
11/03/2020
In this video, Dr Kochenderfer of the National Cancer Institute discusses the findings and clinical significance of the KarMMA study, which looked at the use of anti-BCMA CAR-T therapy for relapsed/refractory multiple myeloma (MM).
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Visit the OLN Excellence Forums
Advertisement
Advertisement
Advertisement